This document discusses antifungal drugs. It begins by describing common fungal infections that antifungals treat, such as ringworm and athlete's foot. It then discusses the different types of fungal infections including superficial infections of the skin and internal organ infections. The document outlines the main biochemical targets of antifungals and describes the structure and mechanisms of several major classes of antifungal drugs, including azoles, polyenes like amphotericin B and nystatin, and the heterocyclic compound griseofulvin. It provides details on specific antifungals like their structures, mechanisms of action, uses, and side effects.
This document discusses several antiviral drugs including acyclovir, ribavirin, and tromantadine hydrochloride. It outlines their mechanisms of action, classifications, structures, and therapeutic uses for treating various viruses. Acyclovir is a nucleoside analogue that acts by terminating viral DNA chain elongation. Ribavirin has broad activity against RNA and DNA viruses by inhibiting viral mRNA capping and GTP synthesis. Tromantadine inhibits viral penetration and uncoating to block herpes simplex virus replication.
This document provides an overview of antiviral drugs, including their mechanisms of action, classifications, and examples. It discusses how antiviral drugs work by inhibiting viral replication and preventing the virus from multiplying, rather than destroying the pathogen. The main classes covered are nucleoside analogs, including purine and pyrimidine analogs like acyclovir and idoxuridine; non-nucleoside reverse transcriptase inhibitors like nevirapine; protease inhibitors used to treat HIV; and miscellaneous agents like foscarnet sodium. For each drug class, examples are given along with descriptions of their structures, mechanisms of action, therapeutic uses, and dosages.
The document provides information about urinary tract infections (UTIs). It discusses the epidemiology, etiology, signs and symptoms, pathogenesis, classification, and treatment of UTIs. It notes that UTIs are commonly caused by bacteria like E. coli and can affect the kidneys (pyelonephritis), bladder (cystitis), or urethra (urethritis). Common signs include pain or burning during urination. Treatment involves antibiotics like sulfonamides, nitrofurantoin, fluoroquinolones, and cephalosporins which can be bacteriostatic or bactericidal.
This document summarizes various anthelmintic drugs used to treat parasitic worm infections. It discusses the drug classes including benzimidazoles, quinolines, piperazine derivatives, vinyl pyrimidines, amides, natural products, and others. It provides details on specific drugs like albendazole, mebendazole, thiabendazole, oxamniquine, praziquantel, piperazine citrate, diethyl carbamazine, pyrantel pamoate, niclosamide, ivermectin, levamisole, metronidazole, and niridazole. It covers their mechanisms of action, structure-
MEDICINAL CHEMISTRY OF ANTI-TUBERCULAR AGENTS.pptxRAJ K. MAURYA
This document discusses anti-tubercular agents used to treat tuberculosis. It describes several common anti-tubercular drugs including isoniazid, ethambutol, para-amino salicylic acid, pyrazinamide, and ethionamide. For each drug, it provides information on their mechanism of action, synthesis, and recommended uses for treating tuberculosis.
The document discusses the structure-activity relationship of quinolines as urinary tract anti-infective agents. It outlines that the 1,4-dihydro-4-oxo-pyridin-3-carboxylic acid moiety is essential for antibacterial activity, and it must be annulated with an aromatic ring. Substitutions at certain positions, like fluorine at position 6, lower alkyl groups at position 1, and amino at position 5 result in compounds with antibacterial activity. Piperazine, N-methyl piperazine and pyrrolidine ring substitutions at position 7 also lead to active compounds.
subscribe the channel :Work&Life Hobbies
watch video:https://www.youtube.com/watch?v=v3rI1lf2TZ8&t=403s
This slide describes the Important Synthesis of Antiviral Drugs
1. The document presents information on the structure-activity relationships of penicillin and cephalosporin.
2. For penicillin, substitutions on the thiazolidine and beta-lactam rings can impact acid stability, antibacterial activity, and resistance to beta-lactamases. Methyl groups and carboxylic acids are important for activity.
3. For cephalosporin, acylation of the amino group increases gram-positive activity but decreases gram-negative activity. Substituents on aromatic rings influence gram-positive versus gram-negative selectivity. Replacing groups on the dihydrothiazine ring can improve properties.
ANTI-TB AND ANTI LEPROTIC DRUGS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR.Dr. Ravi Sankar
This document provides information about anti-tubercular drugs. It discusses various drugs used to treat tuberculosis (TB) including isoniazid, rifampicin, ethambutol, and pyrazinamide. It describes the mechanisms of action, side effects, dosages, and importance of combination therapy to prevent development of drug resistance in TB treatment.
Quinolones are synthetic antibacterial agents derived from nalidixic acid. Modern fluoroquinolones are classified into generations based on potency and spectrum of activity, with later generations having broader coverage. They work by inhibiting bacterial DNA gyrase and topoisomerase IV, preventing DNA replication. Common quinolones include norfloxacin for urinary tract infections, ciprofloxacin with activity against Pseudomonas, and sparfloxacin active against streptococci and anaerobes.
The document discusses the structure, life cycle, and classification of viruses as obligate intracellular parasites. It then summarizes the medicinal chemistry of various classes of anti-viral agents, including their synthesis and mechanisms of action. The main classes covered are adamantane derivatives like amantadine, purine nucleotides like acyclovir, pyrimidine nucleotides like trifluridine, and phosphorus derivatives like foscarnet. The anti-viral agents work by inhibiting viral DNA polymerase, incorporating into viral DNA, or substituting for thymidine in viral DNA synthesis.
This document discusses bioassay methods for quantifying histamine using isolated guinea pig ileum and anesthetized animal models. Histamine is synthesized in mast cells, enterochromaffin cells, and neurons. It mediates effects by binding H1-H4 receptors and causes symptoms like rash and bronchospasm upon mast cell release. Bioassay on guinea pig ileum determines histamine potency by recording contractions, which are induced by H1 receptor agonism. In anesthetized cats or dogs, a standard histamine dose producing a 20mmHg blood pressure fall is used to interpolate test sample doses. These bioassays allow estimation of histamine concentration and pharmacological effects in living tissues.
THIS PRESENTATION ABOUT ANTIMALARIAL DRUGS DETAILING THE COMPLETE INFORMATION ABOUT THE DRUGS USED WITH ITS MECHANISM OF ACTION, STRUCTURAL ACTIVITY AND DOSES.
Protein binding of drugs can significantly impact a drug's pharmacokinetic and pharmacodynamic properties. There are two main classes of protein binding - binding to blood components like plasma proteins and blood cells, and binding to extravascular tissue proteins in organs like the liver, kidneys, lungs, and muscles. The extent of protein binding is influenced by factors related to the drug, such as its lipophilicity and concentration, factors related to the binding protein, such as its concentration and number of binding sites, and patient-related factors like age and disease state. Protein binding impacts a drug's absorption, distribution, metabolism, elimination, and ability to reach its receptor site and produce an effect. It can inactivate drugs by sequestering
This document discusses anti-protozoal drugs used to treat protozoan infections. It describes how protozoan infections are caused by organisms formerly classified as protozoa and are contracted through insect vectors or contact with infected substances. It then outlines several classes of pharmaceuticals used to treat protozoan diseases, including nitroimidazole derivatives like metronidazole, diloxanide, iodoquinol, pentamidine, atovaquone, and eflornithine. It provides details on the structures and mechanisms of action of these various antiprotozoal agents.
Sulphonamides are among the oldest antibacterial agents used to treat infections. They work by competitively inhibiting the enzyme dihydropteroate synthase, blocking folic acid synthesis in bacteria. This makes them bacteriostatic rather than bactericidal. Chemical modifications of the sulphonamide structure have led to important drug classes like diuretics, hypoglycemics, and anti-mycobacterials. Sulphonamides are commonly used to treat urinary tract, respiratory, and other bacterial infections. When combined with trimethoprim, they have broad-spectrum activity against many pathogens and are used as co-trimoxazole. Adverse effects can include allergic reactions and bone marrow suppression.
This document provides information on anti-fungal drugs, including their classification, mechanisms of action, and therapeutic uses. It discusses several major classes of antifungal medications: azoles like fluconazole and itraconazole which inhibit ergosterol synthesis; amphotericin B which binds to ergosterol in fungal cell membranes; flucytosine an antimetabolite; and griseofulvin which disrupts fungal microtubules. These drugs are used to treat superficial fungal infections caused by dermatophytes and yeasts, as well as more serious systemic mycoses depending on their spectrum of antifungal activity and ability to achieve therapeutic drug concentrations
This document provides information on anti-fungal drugs, including their classification, mechanisms of action, and therapeutic uses. It discusses several major classes of antifungal medications: azoles like fluconazole and itraconazole which inhibit ergosterol synthesis; amphotericin B which binds to ergosterol in fungal cell membranes; flucytosine an antimetabolite; and griseofulvin which disrupts fungal microtubules. These drugs are used to treat superficial fungal infections caused by dermatophytes and yeasts, as well as more serious systemic mycoses depending on their spectrum of antifungal activity and ability to achieve therapeutic drug concentrations
This document discusses various types of fungi and fungal infections. It begins by describing the characteristics of fungi, including their cell structure and cell wall composition. It then classifies fungi and describes the types of infections they can cause, including superficial, subcutaneous, systemic, and opportunistic infections. Specific fungal genera and species that cause different types of infections are identified. The document also categorizes and describes various classes of antifungal drugs, including their mechanisms of action, pharmacokinetics, therapeutic uses, and adverse effects. These drug classes include azoles, polyenes like amphotericin B, and echinocandins.
Medicinal Chemistry and Pharmacology of Antifungal Agents and how to take care from fungal infections. Useful Course study material for the undergraduate , postgraduate and aspirants of Pharmacy , Pharmacology and Medicinal Chemistry.
This document provides an overview of anti-fungal drugs. It defines anti-fungal medications as fungicides or fungistatics used to treat mycosis (fungal infections). It classifies anti-fungal drugs into several categories including polyenes, echinocandins, azoles, allylamines, and others. For each category, it describes the mechanisms of action, examples of drugs, pharmacokinetics, adverse effects, and common uses. Key drugs discussed include amphotericin B, griseofulvin, flucytosine, ketoconazole, fluconazole, and terbinafine. The document explains that anti-fungal drugs work by
This document provides an overview of anti-fungal drugs. It begins by classifying antifungals based on their chemical structure, sites of action, and mechanisms of action. The major classes discussed include azoles, polyene macrolides, and other antifungals. Azoles like fluconazole and itraconazole are broad-spectrum and inhibit ergosterol synthesis. Amphotericin B binds to ergosterol and forms pores in fungal membranes. Other antifungals discussed are flucytosine, griseofulvin, and nystatin. The document outlines the mechanisms, therapeutic uses, and adverse effects of the main antifungal drug
Antifungal drugs can be classified based on their structure, mechanism of action, or site of action. The major classes include azoles, polyene macrolides, and others. Azoles like fluconazole and itraconazole inhibit fungal ergosterol synthesis. Amphotericin B binds to ergosterol in fungal membranes. These drugs treat superficial and systemic fungal infections. Common side effects of antifungals include liver toxicity, nausea, and hypokalemia.
This document discusses anti-fungal drugs. It begins by defining fungi and describing their characteristics. It then discusses the structure of fungi including their cell wall, cell membrane, and intracellular components. It notes that anti-fungal drugs target the fungal cell wall, cell membrane, DNA/RNA synthesis, and mitosis. The document categorizes anti-fungal drugs and describes several major classes - polyenes, azoles, echinocandins, griseofulvin, and flucytosine. It provides details on several important anti-fungal drugs, including their mechanisms of action, pharmacokinetics, clinical uses, and side effects.
Viruses rely on host cell processes for replication, so antiviral agents target specific steps in the viral life cycle. Acyclovir inhibits herpes virus DNA synthesis and is used to treat herpes infections. Antiretrovirals target HIV replication through four classes: nucleoside/nucleotide reverse transcriptase inhibitors, protease inhibitors, non-nucleoside reverse transcriptase inhibitors, and fusion inhibitors. Antifungals include polyenes like amphotericin B, which forms pores in fungal cell membranes, and azoles like fluconazole and itraconazole, which inhibit fungal enzyme synthesis. Each drug has characteristic mechanisms, spectrums of activity, and side effect profiles for treating
Viruses rely on host cell processes for replication, so antiviral agents target specific steps in the viral life cycle. Acyclovir inhibits herpes virus DNA synthesis and is used to treat herpes infections. Antiretrovirals for HIV include nucleoside/nonnucleoside reverse transcriptase inhibitors and protease inhibitors. Antifungals include polyenes like amphotericin B, which forms pores in fungal membranes, and azoles like fluconazole and itraconazole, which inhibit fungal enzyme synthesis. These drugs have different mechanisms and are used to treat various fungal infections.
Viruses rely on host cell processes for replication, so antiviral agents target specific steps in the viral life cycle. Acyclovir inhibits herpes virus DNA synthesis and is used to treat herpes infections. Antiretrovirals target HIV replication through four classes: nucleoside/nucleotide reverse transcriptase inhibitors, protease inhibitors, non-nucleoside reverse transcriptase inhibitors, and fusion inhibitors. Amphotericin B and azoles such as fluconazole and itraconazole are broad-spectrum antifungals used to treat serious fungal infections. They work by binding to ergosterol in fungal cell membranes or inhibiting fungal enzyme production.
This document provides an overview of antifungal and anthelminthic drugs. It discusses the structure and types of fungi, classification of antifungal drugs, and drugs used to treat systemic fungal infections. Specifically, it describes the mechanisms of action, clinical uses, and toxicities of amphotericin B and flucytosine, two important drugs for treating systemic fungal infections.
The document discusses different types of fungal diseases (mycoses). It describes four main groups: 1) superficial mycoses which grow on the skin surface, 2) cutaneous mycoses which grow in superficial skin layers like athlete's foot and ringworm, 3) subcutaneous mycoses which penetrate below the skin, and 4) systemic mycoses which can infect internal organs. Examples of different fungal diseases are provided for each group. Common antifungal drugs and their mechanisms of action and side effects are also summarized.
This document discusses various types of antifungal agents. It begins by stating that antifungal medicines are used to treat fungal infections affecting the skin, hair, nails, and other areas. There are hundreds of fungi that can cause infections ranging from common issues like athlete's foot to more serious infections. The document then covers the various classes of antifungal drugs including polyenes such as amphotericin B and nystatin, antimetabolites like flucytosine, azoles including imidazoles and triazoles, and allylamines. It discusses the mechanisms of action, common uses, and side effects of representative drugs within each class.
Amphotericin B is a polyene antifungal drug produced by Streptomyces nodosus that is used intravenously to treat serious systemic fungal infections. It works by binding to ergosterol in the fungal cell membrane, disrupting the membrane and causing leakage of cell contents. While fungi contain ergosterol in their cell membranes, human cells contain cholesterol and are less affected. Common side effects include nephrotoxicity.
Anti-fungal medication is used to treat to fungal infections. They most commonly affect our skin, hair and nails .Nowadays skin problems are found very often.
Antifungal drugs work by targeting differences between fungal and human cell membranes and metabolism. Azoles like fluconazole inhibit ergosterol synthesis while polyenes like amphotericin B bind to ergosterol in the fungal cell membrane. Topical antifungals like nystatin and tolnaftate treat superficial infections while systemic drugs like fluconazole and itraconazole treat deep infections. Common adverse effects include nausea, liver toxicity, and drug interactions. The choice of antifungal depends on the infecting organism, infection severity, and route of administration needed.
Similar to Antifungal agents-Medicinal Chemistry (20)
1. Alkylating agents are a class of anticancer drugs that work by introducing alkyl groups onto DNA, interfering with DNA separation and cell division. Common alkylating agents include nitrogen mustards, cyclophosphamide, ifosfamide, busulfan, nitrosoureas, thiotepa, and procarbazine.
2. These drugs are metabolized in the liver and form reactive metabolites that alkylate guanine bases in DNA, forming crosslinks that prevent cell division. Many require metabolic activation and have toxic metabolites that can cause side effects like hemorrhagic cystitis.
3. Co-administration of drugs like mesna and sodium thiosulfate can help detoxify toxic
This document summarizes several protozoal diseases and their treatment with anti-parasitic drugs. It discusses the diseases giardiasis and amebiasis caused by the protozoa Giardia lamblia and Entamoeba histolytica respectively. It also discusses trichomoniasis caused by Trichomonas vaginalis. The main drugs used to treat these diseases are metronidazole, tinidazole, and nitazoxanide. It provides details on the mechanisms of action and metabolism of these drugs. It also briefly discusses diloxanide furoate and leishmaniasis.
This document summarizes various anti-malarial agents. It discusses the classes of drugs used to treat malaria, including cinchona alkaloids, 4-aminoquinolines, 8-aminoquinolines, diaminopyrimidines, amino alcohols, artemisinins, antibiotics, and fixed combinations. Key drugs discussed include chloroquine, primaquine, pyrimethamine, atovaquone-proguanil, and artemisinin derivatives. The document also briefly discusses vaccine development efforts for malaria.
This document provides an overview of anti-cancer drugs, beginning with an introduction to cancer and statistics on cancer cases in Iraq. It then discusses the classification of anti-cancer drugs according to their chemical structure and mechanisms of action. Specifically, it covers alkylating agents including nitrogen mustards, alkyl sulphonates, nitrosoureas, and aziridines. It provides details on the structures, mechanisms of action, uses, and side effects of common alkylating agents like cyclophosphamide, ifosfamide, busulfan, carmustine, and thiotepa. The document focuses on describing the chemical properties and metabolic pathways that allow these drugs to damage cancer cell DNA and induce cell death.
1. The document discusses several classes of anticancer drugs including antimetabolites, anthracyclines, and natural products.
2. It focuses on antimetabolites such as pyrimidine and purine analogs that interfere with DNA synthesis including 5-fluorouracil, capecitabine, cytarabine, gemcitabine, and 6-mercaptopurine.
3. The mechanisms of these drugs and how they inhibit key enzymes like thymidylate synthase and dihydrofolate reductase is explained.
This document summarizes different classes of anthelmintic drugs used to treat helminth infections. It discusses the chemical structures, mechanisms of action, and metabolism of various classes including benzimidazoles (e.g. albendazole, mebendazole), piperazines (e.g. piperazine citrate, diethylcarbamazine citrate), heterocyclics (e.g. oxamniquine, praziquantel), vinyl pyrimidines (e.g. pyrantel palmoate), amides (e.g. niclosamide), and natural products (e.g. ivermectin). It provides details on the
Parkinson's disease is caused by a loss of dopamine-producing neurons in the substantia nigra. Symptoms include tremors, stiffness, and impaired movement. Anti-Parkinsonian drugs work by increasing dopamine levels in the brain. These include dopamine precursors like levodopa, dopamine receptor agonists, MAO-B inhibitors, COMT inhibitors, and anticholinergic agents. Newer treatments include the dopamine releaser amantadine and drugs that target the adenosine A2A receptor like istradefylline. Deep brain stimulation is also used to treat motor symptoms.
Barbiturates are central nervous system depressants that were historically used as sedatives, hypnotics, and anticonvulsants. They work by enhancing the effects of the neurotransmitter GABA. While largely replaced by safer benzodiazepines, barbiturates are still used for certain medical purposes. Their structure is based on barbituric acid, with activity requiring lipophilic 5,5-disubstitutions for blood-brain barrier crossing. Mechanisms of action, classifications by duration, and metabolism pathways are described.
This document provides information about benzodiazepines, including their history, mechanisms of action, structures, and metabolism. Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA in the brain. They are commonly used to treat anxiety, insomnia, seizures and muscle spasms. The first benzodiazepine developed was chlordiazepoxide in 1955. Key structural features that influence their pharmacological properties include functional groups at the 1st, 2nd, 3rd, 4th, 5th and 7th positions of the benzodiazepine ring system. Metabolism and elimination pathways determine a benzodiazepine's duration of action from short-acting to long-acting
This document provides an overview of β-lactam antibiotics, including penicillins. It begins by classifying common antibiotics and listing their mechanisms of action. It then focuses on β-lactam antibiotics, describing their structure and major subclasses like penicillins, cephalosporins, carbapenems, and monobactams. Specific penicillins are discussed in depth, highlighting their structures, spectra of activity, stability properties, and mechanisms of resistance. β-lactamase inhibitors like clavulanic acid are also introduced.
The document discusses various antiepileptic drugs (AEDs) and their mechanisms of action. It covers major classes of AEDs including valproic acid, phenytoin, carbamazepine, lamotrigine, topiramate, and zonisamide. The main mechanisms of AEDs are enhancement of GABA activity, inhibition of sodium channels, and inhibition of calcium channels. The document discusses the metabolism, pharmacokinetics, indications, contraindications and side effects of the various AEDs. It provides details on the chemical structures and metabolic pathways of many commonly used AEDs.
This document summarizes antipsychotic drugs used to treat psychosis and schizophrenia. It discusses the typical and atypical classes, and provides examples from each class including phenothiazines, butyrophenones, diphenylbutylpiperidines, and others. It describes the mechanism of action involving dopamine receptor antagonism, especially at D2 receptors. Side effects like extrapyramidal symptoms are addressed. Structure-activity relationships are outlined for key drug families.
This document discusses various classes of sedative-hypnotic drugs, including barbiturates and benzodiazepines. It provides details on the classification, mechanisms of action, structure-activity relationships, metabolism and adverse effects of barbiturates. Barbiturates such as phenobarbital, amobarbital and pentobarbital are described according to their duration of action. Their mechanisms involve facilitating GABA neurotransmission. However, barbiturates now see minimal use due to risks of tolerance, dependence and toxicity. Newer drugs like zolpidem and zaleplon were developed to avoid these issues.
"Why Hire Selcuk Ozmumcu? Your Project Partner."Selcuk OZMUMCU
The "Why Hire Selcuk Ozmumcu?" presentation is a compelling showcase of my extensive experience and unique qualifications as a design professional. With over 20 years in industrial design and CAD work, I am passionate about creating innovative and functional products that resonate with users. This presentation emphasizes my commitment to human-centered design principles and the application of design thinking methodologies to ensure that every project addresses real user needs.
Structured for engagement, the presentation begins with my innovative design approach, highlighting how I leverage creativity and originality to deliver tailored solutions. It showcases my versatile skill set, which spans diverse industries, including aerospace, automotive, and brand identity. This breadth of expertise enables me to adapt to various project requirements and effectively tackle diverse challenges.
A key focus of the presentation is my proven leadership abilities, drawn from my experience as the former Vice President of Design & Engineering. I emphasize my dedication to fostering collaboration and innovation within teams, as well as my commitment to mentoring the next generation of designers. This aspect not only highlights my leadership skills but also my investment in the growth and development of team members.
Additionally, I discuss my commitment to quality, illustrating how I integrate a thorough understanding of manufacturing considerations and parametric design techniques to optimize production efficiency without compromising on quality. My approach ensures that every project is executed with precision and attention to detail, providing clients with confidence in the outcomes.
The presentation also emphasizes my global expertise, showcasing my ability to collaborate with clients across various industries and regions. My academic background, which includes a full scholarship in Industrial Design and an MBA, has further enhanced my communication and leadership abilities, allowing me to effectively engage with diverse stakeholders. I am adept at navigating cultural nuances and adapting design practices to meet local needs, ensuring that my solutions are relevant and impactful.
Overall, this presentation serves as a powerful tool to demonstrate why I am the ideal partner for any design project. By combining creativity, technical proficiency, and a collaborative spirit, I am dedicated to achieving exceptional results that align with your vision and objectives. Join me in exploring how my skills and experience can contribute to your next project.
Transform your outdoor space with Melbourne's premier landscape gardeners. Combining expert design, local knowledge, and sustainable practices, they create beautiful, functional gardens tailored to your needs. Utilizing high-quality materials and offering comprehensive services from design to maintenance, these professionals enhance your home's curb appeal and value. Experience exceptional landscaping that thrives in Melbourne’s unique environment.
SS26 Environments & Design Peclers Paris Trend BookPeclers Paris
After celebrating the desirability of sufficiency, magical oneirism emerges as a new keystone of creative inspiration. Enhancing reality with a fantastic halo, unbridled imaginary worlds inspire promising futures.
"Explore the essentials of graphic design through a comprehensive presentation covering its introduction, scope, key elements, fundamental principles, and essential tools. Gain insights into the artistry and functionality behind compelling visual communication."
2. AntifungalDrugs
▪ Antifungal medicines are used to treat fungal infections, which most commonly affect
your skin, hair and nails.
▪ Fungal infections commonly treated with antifungals include:
a. ringworm
b. athlete's foot
c. fungal nail infection
d. vaginal thrush
e. some types of severe dandruff
▪ Some fungal infections can grow inside the body and need to be treated in hospital.
Examples include:
a. aspergillosis, which affects the lungs
b. fungal meningitis, which affects the brain
2
3. Types of fungal infections
1. Superficial : Affect skin – mucous membrane.
a) Tinea versicolor, Dermatophytes : Fungi that affect keratin layer of skin, hair, nail.e.g.tinea pedis ,ring worm
infection
b) Candidiasis : Yeast-like, oral thrush, vulvovaginitis , nail infections.
2. Affect internal organs as : lung ,heart , brain leading to pneumonia , endocarditis , meningitis
3
4. Biochemical Targets for Antifungal Chemotherapy
▪ Antifungal chemotherapy depends on
biochemical differences between fungi
and mammals
▪ Unlike bacteria, which are prokaryotes,
both fungi and mammals are eukaryotes
▪ The fungal cell wall
▪ Other targets for antifungal agents
include inhibitors of DNA biosynthesis,
▪ Sterols
4
8. Antifungal antibiotics
1- Polyene antibiotics :Nystatin& Amphotericin B
2- Heterocyclic Benzofuran: Griseofulvin
Polyene antibiotics (polyene = many double bonds )
➢ Nystatin
▪ Nystatin the first clinically useful polyene antifungal antibiotic, is a conjugated tetraene isolated from cultures
of the bacterium Streptomyces noursei in 1951 .
▪ It is used to treat Candida infections of the skin including diaper rash, thrush, esophageal
candidiasis,gastrointestinal candidiasis and vaginal yeast infections.
▪ Nystatin is too toxic to be used systemically, but because very little drug is absorbed following oral
administration, it may be administered by mouth to treat fungal infections of the mouth and gastrointestinal
tract
▪ It is a similar in structure & mechanism to amphotericin B
▪ Nystatin acts by binding to sterols in the cell membrane of susceptible fungi with a resultant change in
membrane permeability allowing leakage of intracellular components.
▪ Nystatin is an effective topical antifungal against a wide variety of organisms and is available in a variety of
creams and ointments.
8
9. ➢ Amphotericin B
▪ It is an amphoteric compound that consists of seven-conjugated double bond, an internal ester, a free carbonyl group, and a
glycoside side chain with a primary amino group.
▪ The carbohydrate moiety is D-mycosamine. The conjugated systems are usually of all trans configurations, so that the ring
contains a planner lipophilic segment and a less rigid hydrophilic portion.
▪ Amphotericin B, which as a heptaene has low enough toxicity to mammalian cells to permit intravenous (IV)
administration, was discovered in 1956.
▪ The first isolate from the streptomycete was a separable mixture of two compounds, designated amphotericins A and B. In
test cultures, compound B proved to be more active, and this is the one used clinically.
▪ Amphotericin B injection is used to treat serious and potentially life-threatening fungal infections( Systemic Fungal
Infections, Cryptococcal Meningitis, Visceral Leishmaniasis and black fungus)
9
10. 10
▪ Amphotericin B is a very toxic drug and must be used with caution.
▪ Adverse effects include fever, shaking chills, hypotension, and severe kidney toxicity.
▪ More recently developed formulations of amphotericin B, such as liposomal encapsulation and lipid complexes, have
dramatically decreased the toxicity of the drug to humans, which permits higher plasma levels to be employed .
▪ The mechanisms by which the new formulations decrease the toxicity are not entirely clear, but altered distribution is
clearly a factor. Because the blood vessels at the site of infection are more permeable than those of normal tissue, the
large suspended particles of the lipid formulations can penetrate the site of infection more readily than they can
penetrate healthy tissue. The result is selective delivery of drug to the site of infection.
▪ Some evidence also indicates that the newer formulations transfer amphotericin B to ergosterol- containing fungal cells
more efficiently than to cholesterol-containing mammalian cell
▪ The drug cannot cross the blood–brain barrier and must be administered intrathecally for treatment of fungal
infections of the CNS.
11. Mechanism of Action
▪ The lipophilic polyene portion crosses the cell lipid bilayer forming a pore in the cell membrane
▪ Polyenes have a demonstrably higher affinity for membranes containing ergosterol over cholesterol-
containing membranes . This is the basis for their greater toxicity to fungal cells.
▪ Amphotericin B is believed to interact with membrane sterols (ergosterol in fungi) to produce an aggregate
that forms a transmembrane channel. Intermolecular hydrogen bonding interactions among hydroxyl,
carboxyl, and amino groups stabilize the channel in its open form, destroying symport activity and allowing
the cytoplasmic contents to leak out. The effect is similar with cholesterol
11
12. What is 'Black Fungus' or 'Mucormycosis (Zygomycosis)'?: Symptoms and treatment
▪ Mucormycosis, commonly called black fungus, is a serious and rare fungal infection
affecting those suffering from coronavirus in India.
▪ The black fungus that invades the brain is being increasingly seen in vulnerable
patients in India as the health system continues to struggle amid the pandemic.
▪ This infection caused by a group of fungi called mucormycetes. These are ubiquitous
in the environment and can often be seen on rotting food. Despite being common in
the environment, it doesn’t cause infection in humans as our immune cells can easily
fight such pathogens.
▪ Mucormycosis is a deadly fungal infection found in some Covid-19 patients with
uncontrolled diabetes and prolonged intensive care unit (ICU) stay
▪ In COVID-19 patients with diabetes and immuno-suppressed individuals, one must
suspect mucormycosis if there is sinusitis, one-side facial pain or numbness, blackish
discolouration over the bridge of the nose or palate, toothache, blurred or double
vision with pain, skin lesion, thrombosis, chest pain and worsening respiratory
symptoms, it said
▪ Medical treatment (Amphotericin B infusion and anti-fungal therapy for at least six
weeks)
12
13. Heterocyclic Benzofuran:
➢ Griseofulvin
▪ Griseofulvin is an antifungal antibiotic produced by an unusual strain of Penicillium .
▪ Griseofulvin is an antifungal medication used to treat a number of types of dermatophytoses
(ringworm). It is used orally to treat superficial fungal infections, primarily fingernail ,toenail and
scalp infections, but it does not penetrate skin or nails if used topically .
▪ The mechanism of action of griseofulvin is through binding to the protein tubulin, which interferes
with the function of the mitotic spindle and, thereby, inhibits cell division. Griseofulvin also may
interfere directly with DNA replication.
▪ Griseofulvin is absorbed best when it is taken with a high fat meal, such as a cheeseburger, whole
milk, or ice cream.
13
14. Antifungal Azoles
▪ Antifungal Azoles are synthetic drugs with broad-spectrum fungistatic activity. Azoles can be divided into two
groups:
➢ Azole- imidazole agents (clotrimazole, ketoconazole, miconazole) in which the five-member azole nucleus
contains two nitrogens
➢ Newer azole-triazole compounds (fluconazole, itraconazole, and voriconazole), in which the azole nucleus
contains three nitrogens.
14
15. Mechanism of action
▪ All the azoles act by inhibiting ergosterol biosynthesis through
inhibition14a-demethylase, CYP50.
▪ Azoles exert antifungal activity by inhibiting cytochrome P450
enzymes responsible for the demethylation of lanosterol to
ergosterol. Reduced fungal membrane ergosterol
concentrations result in damaged, leaky cell membranes.
▪ The toxicity of these drugs depends on their relative affinities
for mammalian and fungal cytochrome P450 enzymes. The
triazoles tend to have fewer side effects, better absorption,
better drug distribution in body tissues, and fewer drug
interactions.
▪ The basic N3 atom of the azole forms a bond with the heme
iron of the CYP450 prosthetic group in the position normally
occupied by the activated oxygen . The remainder of the azole
antifungal forms bonding interactions with the apoprotein in a
manner that determines the relative selectivity of the drug for
the fungal demethylase versus other CYP450 enzymes
15
16. 1. The basic structural requirement for members of the azole class is a
weakly basic imidazole or 1,2,4-triazole ring (pKaof 6.5–6.8) bonded
by a nitrogen–carbon linkage to the rest of the structure.
2. At the molecular level, the amidine nitrogen atom (N-3 in the
imidazoles, N-4 in the triazoles) is believed to bind to the heme iron
of enzyme-bound cytochrome P450 to inhibit activation of molecular
oxygen and prevent oxidation of steroidal substrates by the enzyme.
3. 3. The most potent antifungal azoles possess two or three aromatic
rings, at least one of which is halogen substituted (e.g., 2,4-
dichlorophenyl, 4-chlorophenyl, 2,4-difluorophenyl), and other
nonpolar functional groups.
4. Only 2, and/or 2,4 substitution yields effective azole compounds.
5. The halogen atom that yields the most potent compounds is
fluorine, although functional groups such as sulfonic acids have been
shown to do the same.
6. Substitution at other positions of the ring yields inactive
compounds.
7. Presumably, the large nonpolar portion of these molecules mimics
the nonpolar steroidal part of the substrate for lanosterol 14-
demethylase, lanosterol, in shape and size.
8. The nonpolar functionality confers high lipophilicity to the
antifungal azoles.
9. The free bases are typically insoluble in water but are soluble in
most organic solvents, such as ethanol.
10. .Fluconazole, which possesses two polar triazole moieties, is an
exception, in that it is sufficiently water soluble to be injected
intravenously as a solution of the free base 16
18. ➢ Ketoconazole
▪ Ketoconazole , an imidazole antifungal, was the first orally active antifungal azole to be discovered and, as a
consequence, has been widely studied and employed for the treatment of systemic fungal infections, primarily
candidiasis. Ketoconazole has little effect on Aspergillus or Cryptococcus.
▪ Ketoconazoleis a highly lipophilic compound. This property leads to high concentrations of ketoconazole in fatty
tissues and purulent exudates.
▪ Ketoconazole is highly dependent on low stomach pH for absorption, and antacids or drugs that raise stomach
pH will lower the bioavailability of ketoconazole.
▪ Evidence that CYP3A4 plays a significant role in metabolism of ketoconazole is that coadministration of CYP3A4
inducers, such as phenytoin, carbamazepine, and rifampin, can cause as much as a 50% reduction in levels of
ketoconazole
▪ Ketoconazole also is a powerful inhibitor of human CYP3A4 and, as a consequence, has many serious
interactions with other drugs. For example, coadministration of ketoconazole with the hypnotic triazolam
results in a 22-fold increase in triazolam’s area under the curve (AUC) and a sevenfold increase in half-life.
18
19. Azole-Triazole compounds
➢ Fluconazole
▪ Fluconazole does not require an acidic environment, as does ketoconazole, for GI absorption. About 80 to 90% of an orally
administered dose is absorbed, yielding high serum drug levels. The t1/2 of the drug is 27 to 37 h, permitting once-daily
dosing in patients with normal renal function.
▪ The drug penetrates widely into most body tissues. Cerebrospinal fluid levels are 60 to 80% of serum levels, permitting
effective treatment for fungal meningitis.
▪ Fluconazole , which was introduced at the same time as itraconazole, differs from ketoconazole and itraconazole in that it is
equally bioavailable when given orally or IV.
▪ Two major advantages of fluconazole over other antifungal agents are that it can cross the blood–brain barrier and has
efficacy against Cryptococcus neoformans . Fluconazole also differs in that it is only a weak inhibitor of CYP3A4 but a
strong inhibitor of CYP2C9 .
▪ Fluconazole is very effective in the treatment of infections with most Candida spp. Thrush in the end-stage AIDS patient,
often refractory to nystatin, clotrimazole, and ketoconazole, can usually be suppressed with oral fluconazole. AIDS patients
with esophageal candidiasis also usually respond to fluconazole. A single 150 mg dose has been shown to be an effective
treatment for vaginal candidiasis. A 3-day course of oral fluconazole is an effective treatment for Candida urinary tract
infection. Stable non-neutropenic patients with candidemia can be adequately treated with fluconazole
19
20. ➢ Voriconazole
▪ Voriconazole is a fluconazole analog that was developed to overcome some of
the limitations of fluconazole and does, indeed, have a broader spectrum of
activity than fluconazole, having activity against Aspergillus and fluconazole-
resistant strains of Candida and Cryptococcus .
▪ Voriconazole is orally absorbed and penetrates the blood–brain barrier.
Unfortunately, voriconazole is extensively metabolized CYP450 enzymes and is
an inhibitor of CYP2C19, CYP2C9, and CYP3A4, leading to many drug
interactions
➢ Posaconazole
▪ Posaconazole , a recently introduced triazole, has a number of advantages
over previous agents . Posaconazole has a wide spectrum of activity
compared to other azoles, particularly against Aspergillus and other
increasingly common nosocomial infections resistant to treatment by
other antifungal drugs.
▪ Posaconazole is structurally similar to itraconazole and saperconazole,
but it contains a tetrahydrofuran ring in place of the dioxolan ring of
those agents, which may account for some of its unique properties.
20
21. Allyl amines and Other Squalene Epoxidase Inhibitors
➢ Terbinafine, Tolnaftate and Naftifine
▪ The group of agents generally known as allylamines strictly includes only naftifine and terbinafine, but
because butenafine and tolnaftate function by the same mechanism of action, they are included in this
class.
▪ Allyl amines reversible noncompetitive
of the fungal enzyme squalene
inhibitors
epoxidase,
lanosterol.
which
With a
converts squalene to
decrease in lanosterol
ergosterol production is also
production,
diminished, affecting fungal cell membrane
synthesis and function. These agents exhibit
fungicidal activity against dermatophytes and
fungistatic activity against yeasts. Squalene
epoxidase forms an epoxide at the C2–C3
studies in the series
position of squalene
▪ Structure–activity
subsequently led to the discovery of
compounds with enhanced potency and
potential oral activity, such as terbinafine.
X
21
22. ➢ Terbinafine
▪ Terbinafine is available in both topical and oral dosage forms and is effective against a
variety of dermatophytic infections when employed topically or systemically . A unique
▪ property of terbinafine is its effectiveness in the treatment of onychomycoses (nail
infections) .
▪ Given orally, the highly lipophilic drug redistributes from the plasma into the nail bed and
into the nail itself, where the infection resides , making terbinafine superior to other
agents for treating this particular type of infection.
➢ Naftifine
▪ Naftifine was the first allylamine to be discovered and marketed . Because of its extensive first-pass
metabolism, naftifine is not used orally and is only available in topical preparations.
▪ The widest use of naftifine is against various tinea infections of the skin.
22
23. Inhibitors of Cell Wall Biosynthesis (inhibition of the enzyme β-1,3-glucan synthase)
➢ Echinocandins
▪ Echinocandins, a group of cyclic peptides with long lipophilic side chains and
sometimes called lipopeptides, have been under investigation for a number
of years .
▪ Echinocandins interfere with cell wall biosynthesis through inhibition of the
enzyme β-1,3-glucan synthase.
▪ β-Glucan is an important polymer component of many fungal cell walls, and
reduction in the glucan content severely weakens the cell wall, leading to
rupture of the fungal cell.
23
24. ➢ Caspofungin
▪ Caspofungin is a semisynthetic lipopeptide. It inhibits the synthesis of beta-D-glucan, a cell wall component of
filamentous fungi.
▪ Caspofungin is approved for the treatment of invasive aspergillosis in patients not responding to amphotericin
B, and itraconazole.
▪ Adverse effects are mediated through histamine release: facial flushing, rash, fever, and pruritus. Dose
reductions are required in the presence of moderate hepatic insufficiency.
24
25. Fluorinated pyrimidines
➢ Flucytosine
▪ Flucytosine (5-flucytosine, 5-FC) is an analogue of cytosine that was originally synthesized for possible use as
an antineoplastic agent
▪ Flucytosine is a powerful antifungal agent used in the treatment of serious systemic fungal infections, such as
Cryptococcus neoformans and Candida spp
▪ Flucytosine itself is not cytotoxic but, rather, is a prodrug that is taken up by fungi and metabolized to 5-fl
uorouracil (5-FU) by fungal cytidine deaminase . Then, 5-FU is converted to 5-fluorodeoxyuridine, which is a
thymidylate synthase inhibitor that interferes with both protein and RNA biosynthesis. 5-Fluorouracil is
cytotoxic and is employed in cancer chemotherapy
▪ Human cells do not contain cytosine deaminase and, therefore, do not convert flucytosine to 5-FU. Some
intestinal flora, however, do convert the drug to 5-FU, so human toxicity does result from this metabolism.
▪ Resistance rapidly develops to flucytosine when used alone, so it is almost always used in conjunction with
amphotericin B. Use of flucytosine has declined since the discovery of fluconazole
Flucytosine, a prodrug, is converted by fungal cytosine deaminase to 5-fluorouracil (5-FU). This reaction does not occur in mammalian cells. A further
transformation of 5-FU to the actual cytotoxic agent 5-fluorodeoxyuridinemonophosphate (5-FdUMP) also occur
25
26. ✓ What is liposomal encapsulation? How does
liposome drug delivery work?
26